Pennant Investors, LP Seres Therapeutics, Inc. Transaction History
Pennant Investors, LP
- $367 Million
- Q2 2024
A detailed history of Pennant Investors, LP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Pennant Investors, LP holds 292,300 shares of MCRB stock, worth $268,916. This represents 0.06% of its overall portfolio holdings.
Number of Shares
292,300
Previous 292,300
-0.0%
Holding current value
$268,916
Previous $225,000
6.67%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding MCRB
# of Institutions
96Shares Held
46.3MCall Options Held
119KPut Options Held
466K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$21.3 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$5.78 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$2.21 Million0.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.78MShares$1.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.62 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $114M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...